Mylan's Semglee Launch Marks US Multi-Source Competition To Lantus

Mylan is the first to launch insulin glargine competition in both a vial and pre-filled pen, joining Eli Lilly's Basaglar pen.

Many Hands Holding the Red Word Competition, Isolated
Mylan's Semglee launches as another insulin glargine option • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas